Skip to main content
PMC home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 2001 Mar;83(2):75–80.

The role of the colonic flora in maintaining a healthy large bowel mucosa.

M A Chapman 1
PMCID: PMC2503330  PMID: 11320933

Abstract

This work explores the intricate relationships between bacterial products of fermentation, the short chain fatty acids and the effect that these have on the colonic epithelium and the immune system. It confirms that butyrate is a major energy source for the colonic epithelium and there may be a minor epithelial abnormality in the metabolism of butyrate in patients with ulcerative colitis. Immunological studies suggest that butyrate has an effect on lymphocyte activation and inhibits cell proliferation. Possibly, butyrate induces anergy in lymphocytes via an effect on the TCR receptor. This may represent a mechanism whereby colonic bacteria are able to regulate the host immune response. An abnormal response to butyrate may upset the homeostasis between the gut immune system and the colonising bacteria resulting in epithelial unrest and inflammation.

Full text

PDF
80

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Burkitt D. P. Epidemiology of cancer of the colon and rectum. Cancer. 1971 Jul;28(1):3–13. doi: 10.1002/1097-0142(197107)28:1<3::aid-cncr2820280104>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  2. Chapman M. A., Grahn M. F., Boyle M. A., Hutton M., Rogers J., Williams N. S. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Gut. 1994 Jan;35(1):73–76. doi: 10.1136/gut.35.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chapman M. A., Grahn M. F., Giamundo P., O'Connell P. R., Onwu D., Hutton M., Maudsley J., Norton B., Rogers J., Williams N. S. New technique to measure mucosal metabolism and its use to map substrate utilization in the healthy human large bowel. Br J Surg. 1993 Apr;80(4):445–449. doi: 10.1002/bjs.1800800412. [DOI] [PubMed] [Google Scholar]
  4. Chapman M. A., Grahn M. F., Hutton M., Williams N. S. Butyrate metabolism in the terminal ileal mucosa of patients with ulcerative colitis. Br J Surg. 1995 Jan;82(1):36–38. doi: 10.1002/bjs.1800820115. [DOI] [PubMed] [Google Scholar]
  5. Chapman M. A., Hutton M., Grahn M. F., Williams N. S. Metabolic adaptation of terminal ileal mucosa after construction of an ileoanal pouch. Br J Surg. 1997 Jan;84(1):71–73. [PubMed] [Google Scholar]
  6. Clausen M. R., Mortensen P. B. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Gut. 1995 Nov;37(5):684–689. doi: 10.1136/gut.37.5.684. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cummings J. H. Short chain fatty acids in the human colon. Gut. 1981 Sep;22(9):763–779. doi: 10.1136/gut.22.9.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Finnie I. A., Taylor B. A., Rhodes J. M. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Gut. 1993 Nov;34(11):1552–1558. doi: 10.1136/gut.34.11.1552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gorbach S. L., Nahas L., Weinstein L., Levitan R., Patterson J. F. Studies of intestinal microflora. IV. The microflora of ileostomy effluent: a unique microbial ecology. Gastroenterology. 1967 Dec;53(6):874–880. [PubMed] [Google Scholar]
  10. Klein S. Short-chain fatty acids and the colon. Gastroenterology. 1992 Jan;102(1):364–365. doi: 10.1016/0016-5085(92)91825-o. [DOI] [PubMed] [Google Scholar]
  11. Mortensen P. B., Clausen M. R. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl. 1996;216:132–148. doi: 10.3109/00365529609094568. [DOI] [PubMed] [Google Scholar]
  12. Roediger W. E. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Lancet. 1980 Oct 4;2(8197):712–715. doi: 10.1016/s0140-6736(80)91934-0. [DOI] [PubMed] [Google Scholar]
  13. Simpson E. J., Chapman M. A., Dawson J., Berry D., Macdonald I. A., Cole A. In vivo measurement of colonic butyrate metabolism in patients with quiescent ulcerative colitis. Gut. 2000 Jan;46(1):73–77. doi: 10.1136/gut.46.1.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Vernia P., Marcheggiano A., Caprilli R., Frieri G., Corrao G., Valpiani D., Di Paolo M. C., Paoluzi P., Torsoli A. Short-chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther. 1995 Jun;9(3):309–313. doi: 10.1111/j.1365-2036.1995.tb00386.x. [DOI] [PubMed] [Google Scholar]
  15. Windmueller H. G. Glutamine utilization by the small intestine. Adv Enzymol Relat Areas Mol Biol. 1982;53:201–237. doi: 10.1002/9780470122983.ch6. [DOI] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES